C Cohen

430 total citations
18 papers, 321 citations indexed

About

C Cohen is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, C Cohen has authored 18 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in C Cohen's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). C Cohen is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). C Cohen collaborates with scholars based in United States, United Kingdom and Australia. C Cohen's co-authors include Kenneth A. Freedberg, Anna N.A. Tosteson, Richard Elion, C. McLaren, Juan González‐García, Carlos Zala, W. Jeffrey Fessel, Rachel T. McGovern, Edward J. Johns and Alex Dusek and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology and Antiviral Research.

In The Last Decade

C Cohen

18 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Cohen United States 10 249 176 80 79 15 18 321
Vincenzo Fragola Italy 11 269 1.1× 183 1.0× 85 1.1× 101 1.3× 10 0.7× 32 320
Sorakij Bhakeecheep Thailand 11 302 1.2× 210 1.2× 96 1.2× 93 1.2× 8 0.5× 19 352
Anitha J. Cecelia India 9 262 1.1× 171 1.0× 87 1.1× 46 0.6× 21 1.4× 10 328
Roberto Zajdenverg Brazil 8 280 1.1× 148 0.8× 114 1.4× 73 0.9× 11 0.7× 13 309
Lucas E. Hermans South Africa 8 290 1.2× 226 1.3× 86 1.1× 40 0.5× 14 0.9× 20 331
Yacine Saïdi France 9 207 0.8× 154 0.9× 44 0.6× 52 0.7× 22 1.5× 12 267
Corinne Rancinan France 8 334 1.3× 248 1.4× 73 0.9× 152 1.9× 26 1.7× 13 424
Eugénio Teófilo Portugal 9 254 1.0× 178 1.0× 74 0.9× 63 0.8× 13 0.9× 22 319
Amani Anzian Ivory Coast 6 380 1.5× 225 1.3× 142 1.8× 123 1.6× 6 0.4× 7 433
Alberto Arranz Spain 10 473 1.9× 334 1.9× 47 0.6× 146 1.8× 17 1.1× 16 504

Countries citing papers authored by C Cohen

Since Specialization
Citations

This map shows the geographic impact of C Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Cohen more than expected).

Fields of papers citing papers by C Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Cohen. The network helps show where C Cohen may publish in the future.

Co-authorship network of co-authors of C Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of C Cohen. A scholar is included among the top collaborators of C Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Cohen. C Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nelson, Mark, Richard Elion, C Cohen, et al.. (2013). Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies. HIV Clinical Trials. 14(3). 81–91. 46 indexed citations
2.
Cohen, C, Kevin Davis, & Juliana Meyers. (2012). Association of partial adherence (PA) to antiretroviral therapy with hospitalizations and healthcare costs in an HIV population. Journal of the International AIDS Society. 15(S4). 18060–301. 9 indexed citations
3.
Cohen, C, Homayoun Khanlou, W. J. Burman, et al.. (2012). A randomized pilot study of tenofovir/emtricitabine (TDF/FTC) + boosted atazanavir (ATV/r) vs. raltegravir (RAL BID) + ATV/r vs. RAL BID + ATV BID. Journal of the International AIDS Society. 15(S4). 1–1. 9 indexed citations
4.
5.
Wayne, Peter M., Douglas P. Kiel, J. E. Buring, et al.. (2012). OA06.02. Impact of Tai Chi exercise on multiple fracture-related risk factors in post-menopausal osteopenic women: a pilot pragmatic, randomized trial. BMC Complementary and Alternative Medicine. 12(S1). 1 indexed citations
6.
7.
Ross, Lisa, Peter Gerondelis, E DeJesus, et al.. (2009). Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. Journal of Antimicrobial Chemotherapy. 65(2). 307–315. 6 indexed citations
8.
9.
Cohen, C, Amy E. Colson, Gerald Pierone, et al.. (2008). O214 The FOTO study: 24-week results support the safety of a 2-day break on efavirenz-based antiretroviral therapy. Journal of the International AIDS Society. 11(Suppl 1). O19–O19. 7 indexed citations
10.
Coyne, Katherine, C Cohen, Sundhiya Mandalia, & Alan McOwan. (2007). KC60 coding: room for improvement – a study into consistencies and inconsistencies in the use of diagnosing codes. International Journal of STD & AIDS. 18(2). 118–119. 1 indexed citations
11.
Cohen, C, Carlos Zala, W. Jeffrey Fessel, et al.. (2005). Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial. Current Medical Research and Opinion. 21(10). 1683–1692. 72 indexed citations
12.
Sacks, Steven H., P. D. Griffiths, Lawrence Corey, et al.. (2004). HSV-2 transmission. Antiviral Research. 63. S27–S35. 34 indexed citations
13.
14.
Hellinger, James, et al.. (2000). Efficacy of Nelfinavir in Patients Switched from Ritonavir/Saquinavir Combination Antiretroviral Therapy. HIV Clinical Trials. 1(2). 25–28. 2 indexed citations
15.
Elion, Richard & C Cohen. (1997). COMPLEMENTARY MEDICINE AND HIV INFECTION. Primary Care Clinics in Office Practice. 24(4). 905–919. 8 indexed citations
16.
Laroche, F., et al.. (1994). Ketoprofen and prednisolone do not modulate neutrophil CR1, CR3 and Fc gamma RIII expression in healthy volunteers.. British Journal of Clinical Pharmacology. 38(5). 441–445. 1 indexed citations
17.
Freedberg, Kenneth A., et al.. (1991). Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.. PubMed. 4(5). 521–31. 48 indexed citations
18.
Cohen, C, et al.. (1982). Familial Syringomyelia with Mental Impairment. Journal of the Royal Army Medical Corps. 128(1). 41–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Fragola Breakdown of academic impact, for papers by Sorakij Bhakeecheep Breakdown of academic impact, for papers by Anitha J. Cecelia Breakdown of academic impact, for papers by Roberto Zajdenverg Breakdown of academic impact, for papers by Lucas E. Hermans Breakdown of academic impact, for papers by Yacine Saïdi Breakdown of academic impact, for papers by Corinne Rancinan Breakdown of academic impact, for papers by Eugénio Teófilo Breakdown of academic impact, for papers by Amani Anzian Breakdown of academic impact, for papers by Alberto Arranz
Rankless by CCL
2026